Financial incentives to improve glycemic control in African American adults with type 2 diabetes: a pilot randomized controlled trial

Leonard E Egede, Jennifer A Campbell, Rebekah J Walker, Aprill Z Dawson, Joni S Williams, Leonard E Egede, Jennifer A Campbell, Rebekah J Walker, Aprill Z Dawson, Joni S Williams

Abstract

Background: Financial incentives is emerging as a viable strategy for improving clinical outcomes for adults with type 2 diabetes. However, there is limited data on optimal structure for financial incentives and whether financial incentives are effective in African Americans with type 2 diabetes. This pilot study evaluated impact of three financial incentive structures on glycemic control in this population.

Methods: Sixty adults with type 2 diabetes were randomized to one of three financial incentive structures: 1) single incentive (Group 1) at 3 months for Hemoglobin A1c (HbA1c) reduction, 2) two-part equal incentive (Group 2) for home testing of glucose and HbA1c reduction at 3 months, and 3) three-part equal incentive (Group 3) for home testing, attendance of weekly telephone education classes and HbA1c reduction at 3 months. The primary outcome was HbA1c reduction within each group at 3 months post-randomization. Paired t-tests were used to test differences between baseline and 3-month HbA1c within each group.

Results: The mean age for the sample was 57.9 years and 71.9% were women. Each incentive structure led to significant reductions in HbA1c at 3 months with the greatest reduction from baseline in the group with incentives for multiple components: Group 1 mean reduction = 1.25, Group 2 mean reduction = 1.73, Group 3 mean reduction = 1.74.

Conclusion: Financial incentives led to significant reductions in HbA1c from baseline within each group. Incentives for multiple components led to the greatest reductions from baseline. Structured financial incentives that reward home monitoring, attendance of telephone education sessions, and lifestyle modification to lower HbA1c are viable options for glycemic control in African Americans with type 2 diabetes.

Trial registration: Trial registration: NCT02722499 . Registered 23 March 2016, url.

Keywords: African American; Diabetes; Financial incentives; Glycemic control; Randomized controlled trial.

Conflict of interest statement

The authors declare they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Consort Flow Diagram

References

    1. Center for Disease Control and Prevention . National Diabetes Statistics Report. 2020.
    1. Egede LE, Dagogo-Jack S. Epidemiology of type 2 diabetes: focus on ethnic minorities. Med Clin North Am. 2005;89(5):949–975. doi: 10.1016/j.mcna.2005.03.004.
    1. Nwasuruba C, Khan M, Egede LE. Racial/ethnic differences in multiple self-care behaviors in adults with diabetes. J Gen Intern Med. 2007;22(1):115–120. doi: 10.1007/s11606-007-0120-9.
    1. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care. 1995;18(7):943–949. doi: 10.2337/diacare.18.7.943.
    1. Egede LE, Mueller M, Echols CL, Gebregziabher M. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes. Med Care. 2010;48(6):527–533. doi: 10.1097/MLR.0b013e3181d558dc.
    1. American Diabetes Association Improving care and promoting health in populations: standards of medical Care in Diabetes – 2020. Diabetes Care. 2020;43(Supplement 1):S7–S13. doi: 10.2337/dc20-S001.
    1. Centers for Disease Control and Prevention. Percentage of adults aged 18 years or older with diagnosed diabetes receiving a dilated eye exam in the last year, by race/ethnicity, United States; 1994–2010.
    1. Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016;23(4):327–337. doi: 10.1177/107327481602300404.
    1. McMahon GT, Gomes HE, Hohne SH, Hu TM, Levine BA, Conlin PR. Web-based care management in patients with poorly controlled diabetes. Diabetes Care. 2005;28(7):1624–1629. doi: 10.2337/diacare.28.7.1624.
    1. Stone RA, Rao RH, Sevick MA, Cheng C, Hough LJ, Macpherson DS, et al. Active care management supported by home telemonitoring in veterans with type 2 diabetes: the DiaTel randomized controlled trial. Diabetes Care. 2010;33(3):478–484. doi: 10.2337/dc09-1012.
    1. Egede LE, Poston ME. Racial/ethnic differences in leisure-time physical activity levels among individuals with diabetes. Diabetes Care. 2004;27(10):2493–2494. doi: 10.2337/diacare.27.10.2493.
    1. Peña-Purcell NC, Jiang L, Ory MG, Hollingsworth R. Translating an evidence-based diabetes education approach into rural African-American communities: the “wisdom, power, control” program. Diab Spectrum. 2015;28(2):106–115. doi: 10.2337/diaspect.28.2.106.
    1. Egede LE, Williams JS, Voronca DC, Knapp RG, Fernandes JK. Randomized controlled trial of technology-assisted case management in low income adults with type 2 diabetes. Diabetes Technol Ther. 2017;19(8):476–482. doi: 10.1089/dia.2017.0006.
    1. Whittemore R, Melkus GD, Sullivan A, Grey M. A nurse-coaching intervention for women with type 2 diabetes. Diab Educ. 2004;30(5):795–804. doi: 10.1177/014572170403000515.
    1. Williams JS, Lynch CP, Knapp RG, Egede LE. Technology-intensified diabetes education study (TIDES) in African Americans with type 2 diabetes: study protocol for a randomized controlled trial. Trials. 2014;15:460. doi: 10.1186/1745-6215-15-460.
    1. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24(3):561–587. doi: 10.2337/diacare.24.3.561.
    1. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002;25(7):1159–1171. doi: 10.2337/diacare.25.7.1159.
    1. Sarkar U, Piette JD, Gonzales R, et al. Preferences for self-management support: findings from a survey of diabetes patients in safety-net health systems. Patient Educ Couns. 2008;70(1):102–110. doi: 10.1016/j.pec.2007.09.008.
    1. Weinberger M, Kirkman MS, Samsa GP, et al. A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med. 1995;10(2):59–66. doi: 10.1007/BF02600227.
    1. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care. 2001;24(2):202–208. doi: 10.2337/diacare.24.2.202.
    1. Young RJ, Taylor J, Friede T, et al. Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care. 2005;28(2):278–282. doi: 10.2337/diacare.28.2.278.
    1. Shea S, Weinstock RS, Starren J, et al. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc. 2006;13(1):40–51. doi: 10.1197/jamia.M1917.
    1. Long JA, Jahnle EC, Richardson DM, Loewenstein G, Volpp KG. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial. Ann Intern Med. 2012;156(6):416–424. doi: 10.7326/0003-4819-156-6-201203200-00004.
    1. Reynolds B. A review of delay-discounting research with humans: relations to drug use and gambling. Behav Pharmacol. 2006;17(8):651–667. doi: 10.1097/FBP.0b013e3280115f99.
    1. Thaler RH. Behavioral economics: past, present, and future. Am Econ Rev. 2016;106(7):1577–1600. doi: 10.1257/aer.106.7.1577.
    1. Sutherland K, Christianson JB, Leatherman S. Impact of targeted financial incentives on personal health behavior: a review of the literature. Med Care Res Rev. 2008;65(6 Suppl):36S–78S. doi: 10.1177/1077558708324235.
    1. Fernandes R, Chinn CC, Li D, et al. Financial incentives for Medicaid beneficiaries with diabetes: lessons learned from HI-PRAISE, an observational study and randomized controlled trial. Am J Health Promot. 2018;32(7):1498–1501. doi: 10.1177/0890117117746335.
    1. Fernandes R, Chinn CC, Li D, et al. A randomized controlled trial of financial incentives for Medicaid beneficiaries with diabetes. Perm J. 2018;22:17–080.
    1. Johnson-Spruill I, Hammond P, Davis B, McGee Z, Louden D. Health of Gullah families in South Carolina with type 2 diabetes. Diab Educ. 2009;35(1):117–123. doi: 10.1177/0145721708327535.
    1. Jackson T, Shields MD, Heaney LG, Kendall M, Pearce CJ, Hui CY, et al. The impact of financial incentives on the implementation of asthma or diabetes self-management: a systematic review. PLoS One. 2017;12(11):e0187478. doi: 10.1371/journal.pone.0187478.
    1. Egede LE, Strom JL, Fernandes J, Knapp RG, Rojugbokan A. Effectiveness of technology-assisted case management in low income adults with type 2 diabetes (TACM-DM): study protocol for a randomized controlled trial. Trials. 2011;12(1):231. doi: 10.1186/1745-6215-12-231.
    1. Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272. doi: 10.1186/1472-6963-8-272.
    1. Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–2637. doi: 10.1001/jama.2008.804.
    1. Volpp KG, Troxel AB, Pauly MV, et al. A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009;360(7):699–709. doi: 10.1056/NEJMsa0806819.
    1. Promberger M, Dolan P, Marteau TM. “Pay them if it works”: discrete choice experiments on the acceptability of financial incentives to change health related behaivour. Soc Sci Med. 2012;75:2509–2514. doi: 10.1016/j.socscimed.2012.09.033.
    1. Purnell JQ, Gernes R, Stein R, Sherraden MS, Knoblock-Hahn A. A systematic review of financial incentives for dietary behavior change. J Acad Nutr Diet. 2014;114(7):2212–2672. doi: 10.1016/j.jand.2014.03.011.
    1. Blondon KS. Patient attitudes about financial incentives for diabetes self-management: a survey. World J Diabetes. 2015;6:752–758. doi: 10.4239/wjd.v6.i5.752.
    1. DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;55:S86–S94. doi: 10.1016/j.ypmed.2012.04.017.
    1. Mantzari E, Vogt F, Shemilt I, Wei Y, Higgins JPT, Marteau TM. Personal financial incentives for changing habitual health-related behaviors: a systematic review and meta-analysis. Prev Med. 2015;75:75–85. doi: 10.1016/j.ypmed.2015.03.001.
    1. Giles EL, Robalino S, McColl E, Sniehotta FF, Adams J. The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS One. 2014;9:e90347. doi: 10.1371/journal.pone.0090347.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi